Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
TRAIL on trial: preclinical advances in cancer therapy
Daniel W. Stuckey et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma
Chung Heon Ryu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Expressed Cell-penetrating Peptides Can Induce a Bystander Effect, but Passage Through the Secretory Pathway Reduces Protein Transduction Activity
Ying Shen et al.
MOLECULAR THERAPY (2011)
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi et al.
CANCER RESEARCH (2010)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Andrea Mohr et al.
STEM CELLS (2010)
Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction
Michael P. Francis et al.
ORGANOGENESIS (2010)
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
Xiaoyang Ling et al.
CANCER MICROENVIRONMENT (2010)
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
Tamer E. Fandy et al.
MOLECULAR CANCER (2008)
Isolation murine mesenchymal stem cells by positive selection
Samad Nadri et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2007)
Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIPL and XIAP protein levels and ERK activation
Tae-Jin Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells
KM Bockbrader et al.
ONCOGENE (2005)
Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein
XF Wu et al.
MOLECULAR THERAPY (2001)
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
SM Srinivasula et al.
NATURE (2001)
Share Paper
